From: Intratumoral hyperthermic chemotherapy injection in peripheral non-small cell lung cancer
Group A (n = 10) | Group B (n = 10) | Group C (n = 10) | P value | ||||
---|---|---|---|---|---|---|---|
No | % | No | % | No | % | ||
Post 3 months | P1 = 0.654, P2 = 0.006, P3 = 0.010 | ||||||
Complete response | 0 | 0% | 0 | 0% | 0 | 0% | |
Partial response | 8 | 80% | 7 | 70% | 2 | 20% | |
Stable | 1 | 10% | 2 | 20% | 1 | 10% | |
Progression | 1 | 10% | 1 | 10% | 7 | 70% | |
Post 6 months | P1 = 0.548, P2 = 0.019, P3 = 0.032 | ||||||
Complete response | 1 | 10% | 0 | 0% | 0 | 0% | |
Partial response | 6 | 60% | 6 | 60% | 2 | 20% | |
Stable | 1 | 10% | 2 | 20% | 1 | 10% | |
Progression | 2 | 20% | 2 | 20% | 7 | 70% |